DopamineOxidopamineReceptors, Dopamine D2alpha-MethyltyrosineDopamine AntagonistsCorpus StriatumReceptors, Dopamine D1Dopamine AgonistsParkinsonian DisordersAdrenergic AgentsDopamine AgentsReceptors, DopamineSympatholytics1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineReceptors, Dopamine D3Substantia NigraTyrosine 3-MonooxygenaseGlobus PallidusMPTP PoisoningLevodopaNeostriatumDopamine Plasma Membrane Transport ProteinsParkinson Disease, SecondaryStereotypic Movement DisorderDopaminergic NeuronsBasal GangliaHomovanillic AcidApomorphineNucleus AccumbensHaloperidolRats, Sprague-DawleyBiogenic MonoaminesReceptors, Dopamine D5Parkinson DiseaseAmphetamineDopamine Uptake Inhibitors3,4-Dihydroxyphenylacetic AcidHydroxydopaminesCaudate NucleusBehavior, AnimalVanilmandelic AcidMetanephrineSubthalamic NucleusReserpineDopamine beta-HydroxylaseNeural PathwaysAntiparkinson AgentsMotor ActivityMethamphetamineNeuronsSerotoninQuinpiroleAnalysis of VarianceBenzazepinesDisease Models, AnimalCarthamusBrainTime FactorsLymphocyte DepletionSulpirideMice, Inbred C57BLReaction TimeAction PotentialsRats, WistarSalicylamidesCocaineDopamine and cAMP-Regulated Phosphoprotein 32MicrodialysisSpiperoneVentral Tegmental AreaMesencephalonErgolinesDomperidoneDihydroxyphenylalanineDose-Response Relationship, DrugNomifensineFlupenthixolVesicular Monoamine Transport ProteinsRewardTropanesBromocriptinePutamenButaclamolNorepinephrinePrefrontal CortexCatecholaminesCentral Nervous System StimulantsNerve Tissue ProteinsBrain ChemistryMedial Forebrain BundleStereotyped BehaviorSynaptic TransmissionAntipsychotic AgentsMice, KnockoutDextroamphetamineExtracellular SpaceCarbidopaCells, CulturedPergolideLimbic System